ArticleClinical epigenetics2016

MGMT promoter methylation determined by HRM in comparison to MSP and pyrosequencing for predicting high-grade glioma response.

Olivier J Switzeny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.